BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16870758)

  • 21. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
    Vandendriessche S; Kadlec K; Schwarz S; Denis O
    J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4')-Ia and the efflux pump genes msrA/msrB.
    Pérez-Vázquez M; Vindel A; Marcos C; Oteo J; Cuevas O; Trincado P; Bautista V; Grundmann H; Campos J;
    J Antimicrob Chemother; 2009 Jan; 63(1):21-31. PubMed ID: 18948410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong.
    Ip M; Yung RW; Ng TK; Luk WK; Tse C; Hung P; Enright M; Lyon DJ
    J Clin Microbiol; 2005 Oct; 43(10):5069-73. PubMed ID: 16207964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal cassette chromosome mec (SCCmec) characterization and panton-valentine leukocidin gene occurrence for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006.
    Kilic A; Guclu AU; Senses Z; Bedir O; Aydogan H; Basustaoglu AC
    Antonie Van Leeuwenhoek; 2008 Nov; 94(4):607-14. PubMed ID: 18752036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
    Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
    [No Abstract]   [Full Text] [Related]  

  • 27. Polyclonal presence of non-multiresistant methicillin-resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associated infections in a hospital in Rio de Janeiro, Brazil.
    Schuenck RP; Nouér SA; Winter Cde O; Cavalcante FS; Scotti TD; Ferreira AL; Giambiagi-de Marval M; dos Santos KR
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):434-41. PubMed ID: 19631097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia.
    Baranovich T; Zaraket H; Shabana II; Nevzorova V; Turcutyuicov V; Suzuki H
    Clin Microbiol Infect; 2010 Jun; 16(6):575-82. PubMed ID: 19681959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes.
    Berglund C; Mölling P; Sjöberg L; Söderquist B
    Clin Microbiol Infect; 2005 Jun; 11(6):447-56. PubMed ID: 15882194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
    Saravolatz LD; Pawlak J; Johnson LB
    J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI.
    Conceição T; Tavares A; Miragaia M; Hyde K; Aires-de-Sousa M; de Lencastre H
    Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):543-50. PubMed ID: 20229224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium.
    Denis O; Jans B; Deplano A; Nonhoff C; De Ryck R; Suetens C; Struelens MJ
    J Antimicrob Chemother; 2009 Dec; 64(6):1299-306. PubMed ID: 19808236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones.
    Marchese A; Gualco L; Maioli E; Debbia E
    Int J Antimicrob Agents; 2009 Nov; 34(5):424-8. PubMed ID: 19651493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of methicillin-resistant Staphylococcus aureus resistant to tigecycline and daptomycin isolated in a hospital in Brazil.
    Dabul AN; Camargo IL
    Epidemiol Infect; 2014 Mar; 142(3):479-83. PubMed ID: 23714160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia.
    Budimir A; Deurenberg RH; Bosnjak Z; Stobberingh EE; Cetkovic H; Kalenic S
    Clin Microbiol Infect; 2010 Aug; 16(8):1077-83. PubMed ID: 19732087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
    Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM
    Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
    Mendes RE; Deshpande LM; Costello AJ; Farrell DJ; Jones RN; Flamm RK
    Microb Drug Resist; 2016 Jan; 22(1):53-8. PubMed ID: 26230870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of methicillin-resistant Staphylococcus aureus nasal isolates from Turkey.
    Kilic A; Mert G; Senses Z; Bedir O; Aydogan H; Basustaoglu AC; Appelbaum PC
    Antonie Van Leeuwenhoek; 2008 Nov; 94(4):615-9. PubMed ID: 18683075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of methicillin-resistant Staphylococcus aureus bloodstream isolates from Croatia.
    Budimir A; Deurenberg RH; Plecko V; Vink C; Kalenic S; Stobberingh EE
    J Antimicrob Chemother; 2006 Feb; 57(2):331-4. PubMed ID: 16339843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital.
    Naas T; Fortineau N; Spicq C; Robert J; Jarlier V; Nordmann P
    J Hosp Infect; 2005 Dec; 61(4):321-9. PubMed ID: 16026895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.